We believe this is due to loss of Mertk resulting in decreased T cell suppression in the tumor environment rather than increased numbers of T cells, but the contribution of adaptive immune cells remains to be determined, including potential effects on distant, untreated tumors. The gene discussed is MERTK; the disease is neoplasm.